An analysis of FDA-approved drugs for psychiatric disorders

被引：15

作者：

Kinch, Michael S. ^{[1
,2
]}

Patridge, Eric ^{[2
]}

机构：

[1] Washington Univ, St Louis, MO 63130 USA

[2] Yale Ctr Mol Discovery, West Haven, CT 06516 USA

来源：

DRUG DISCOVERY TODAY | 2015年 / 20卷 / 03期

关键词：

BIAS;

D O I：

10.1016/j.drudis.2014.08.013

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：292 / 295

页数：4

共 50 条

[1] An analysis of FDA-approved drugs for neurological disorders
Kinch, Michael S.
DRUG DISCOVERY TODAY, 2015, 20 (09) : 1040 - 1043
[2] FDA-APPROVED DRUGS TO TREAT SLEEP DISORDERS
不详
JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2018, 56 (10)
[3] An analysis of FDA-approved drugs for oncology
Kinch, Michael S.
DRUG DISCOVERY TODAY, 2014, 19 (12) : 1831 - 1835
[4] An analysis of FDA-approved drugs for metabolic diseases
Kinch, Michael S.
Umlauf, Sheila
Plummer, Mark
DRUG DISCOVERY TODAY, 2015, 20 (06) : 648 - 651
[5] An analysis of FDA-approved drugs for pain and anesthesia
Kinch, Michael S.
DRUG DISCOVERY TODAY, 2015, 20 (01) : 3 - 6
[6] An analysis of FDA-approved drugs for cardiovascular diseases
Kinch, Michael S.
Surovtseva, Yulia
Hoyer, Denton
DRUG DISCOVERY TODAY, 2016, 21 (01) : 1 - 4
[7] A systematic analysis of FDA-approved anticancer drugs
Sun, Jingchun
Wei, Qiang
Zhou, Yubo
Wang, Jingqi
Liu, Qi
Xu, Hua
BMC SYSTEMS BIOLOGY, 2017, 11 : 27 - 43
[8] An analysis of FDA-approved drugs: natural products and their derivatives
Patridge, Eric
Gareiss, Peter
Kinch, Michael S.
Hoyer, Denton
DRUG DISCOVERY TODAY, 2016, 21 (02) : 204 - 207
[9] An analysis of FDA-approved drugs for inflammation and autoimmune diseases
Kinch, Michael S.
Merkel, Janie
DRUG DISCOVERY TODAY, 2015, 20 (08) : 920 - 923
[10] Safety of FDA-Approved drugs - Reply
Friedman, MA
Woodcock, J
Lumpkin, MM
Shuren, JE
Hass, AE
Thompson, LJ
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (24): : 2297 - 2298

← 1 2 3 4 5 →